These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23027945)

  • 1. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.
    Lee PS; Yoshida R; Ekiert DC; Sakai N; Suzuki Y; Takada A; Wilson IA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17040-5. PubMed ID: 23027945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
    Xu R; Ekiert DC; Krause JC; Hai R; Crowe JE; Wilson IA
    Science; 2010 Apr; 328(5976):357-60. PubMed ID: 20339031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-neutralization of influenza A viruses mediated by a single antibody loop.
    Ekiert DC; Kashyap AK; Steel J; Rubrum A; Bhabha G; Khayat R; Lee JH; Dillon MA; O'Neil RE; Faynboym AM; Horowitz M; Horowitz L; Ward AB; Palese P; Webby R; Lerner RA; Bhatt RR; Wilson IA
    Nature; 2012 Sep; 489(7417):526-32. PubMed ID: 22982990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
    Williams JA; Gui L; Hom N; Mileant A; Lee KK
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.
    Lee PS; Ohshima N; Stanfield RL; Yu W; Iba Y; Okuno Y; Kurosawa Y; Wilson IA
    Nat Commun; 2014 Apr; 5():3614. PubMed ID: 24717798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.
    Beer K; Dai M; Howell S; Rijal P; Townsend AR; Lin Y; Wharton SA; Daniels RS; McCauley JW
    J Gen Virol; 2018 Aug; 99(8):1001-1011. PubMed ID: 29944110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
    Muramatsu M; Yoshida R; Yokoyama A; Miyamoto H; Kajihara M; Maruyama J; Nao N; Manzoor R; Takada A
    PLoS One; 2014; 9(1):e85582. PubMed ID: 24465606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly conserved neutralizing epitope on group 2 influenza A viruses.
    Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
    Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
    Hong M; Lee PS; Hoffman RM; Zhu X; Krause JC; Laursen NS; Yoon SI; Song L; Tussey L; Crowe JE; Ward AB; Wilson IA
    J Virol; 2013 Nov; 87(22):12471-80. PubMed ID: 24027321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
    Tsibane T; Ekiert DC; Krause JC; Martinez O; Crowe JE; Wilson IA; Basler CF
    PLoS Pathog; 2012; 8(12):e1003067. PubMed ID: 23236279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
    Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
    Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.
    Shibuya T; Yamashiro T; Masaike Y; Ohuchi M; Uechi G; Nishizono A
    Microbiol Immunol; 2008 Mar; 52(3):162-70. PubMed ID: 18402598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and genetic basis for development of broadly neutralizing influenza antibodies.
    Lingwood D; McTamney PM; Yassine HM; Whittle JR; Guo X; Boyington JC; Wei CJ; Nabel GJ
    Nature; 2012 Sep; 489(7417):566-70. PubMed ID: 22932267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses.
    Huang JW; Yang JM
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S31. PubMed ID: 21342562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.